ABBOTT LABORATORIES Short-Term Debt 2007-2026 | ABT
Beta
What is short-term debt?
Short-term debt includes borrowings and the current portion of long-term debt due within one year.
What is ABBOTT LABORATORIES's current short-term debt?
ABBOTT LABORATORIES (ABT) annual short-term debt for 2025 was $3.03B, a 102.20% increase from 2024. ABBOTT LABORATORIES short-term debt for the quarter ending March 31, 2026 was $4.41B.
What was ABBOTT LABORATORIES's short-term debt in 2024?
ABBOTT LABORATORIES annual short-term debt for 2024 was $1.50B, a 38.89% increase from 2023.
What was ABBOTT LABORATORIES's short-term debt in 2023?
ABBOTT LABORATORIES annual short-term debt for 2023 was $1.08B, a 52.02% decline from 2022.
What is ABBOTT LABORATORIES's 5-year short-term debt CAGR?
ABBOTT LABORATORIES short-term debt grew at a compound annual growth rate (CAGR) of 70.10% from FY2020 to FY2025, going from $213.0M to $3.03B over 5 years.
Short-Term Debt History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+70.1%
FY2020
$213.0M
→
FY2025
$3.03B
07080910111213141516171819202122232425
5 years selected
Short-Term Debt History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $3.03B | +102.2% | 10-K |
| FY2024 | $1.50B | +38.9% | 10-K |
| FY2023 | $1.08B | -52.0% | 10-K |
| FY2022 | $2.25B | - | 10-K |
| FY2021 | $0 | -100.0% | 10-K |
| FY2020 | $213.0M | -83.3% | 10-K |
| FY2019 | $1.28B | +538.5% | 10-K |
| FY2018 | $200.0M | -60.6% | 10-K |
| FY2017 | $508.0M | -61.6% | 10-K |
| FY2016 | $1.32B | -57.7% | 10-K |
| FY2015 | $3.13B | -28.6% | 10-K |
| FY2014 | $4.38B | +38.5% | 10-K |
| FY2013 | $3.16B | +52.0% | 10-K |
| FY2012 | $2.08B | -11.3% | 10-K |
| FY2011 | $2.35B | -46.0% | 10-K |
| FY2010 | $4.35B | -12.6% | 10-K |
| FY2009 | $4.98B | +194.4% | 10-K |
| FY2008 | $1.69B | -7.5% | 10-K |
| FY2007 | $1.83B | - | 10-K |
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →